Digital Health Funding Reaches Record Level

Digital Health Funding Reaches Record Level

Large deals to GRAIL and Hao Daifu in Q1’17 pushed global funding up 100% over Q4’16.

Deals to digital health startups fell for the first time in 4 years in 2016. Global funding into the sector, however, grew for the 7th straight year in large part due to sizable rounds to Oscar Health Insurance and Ping An Haoyisheng.

And 2017 is off to a strong start. This past week has seen the $20M Series A of medication delivery service Capsule and the $11M Series A of online prescription platform Lemonaid Health. Novartis Venture Funds participated in Lemonaid’s round, echoing the trend of pharmaceutical giants making increasingly more bets on digital health startups.

Using CB Insights data, we analyzed deal and dollar trends on an annual and quarterly basis to the digital health sector. We define digital health as companies in the healthcare space that use software as a central piece of the company’s product offering, including but not limited to mobile health, telemedicine, genomics, and electronic medical records. Products like pharmaceuticals, mechanical devices, and hospital systems are excluded.

Read full report here.


    Popular posts

    Related posts